Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle M Kampman

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
The American Journal of Drug and Alcohol Abuse|October 29, 2025
Racial and ethnic disparities in buprenorphine retention and treatment outcome in a longitudinal cohort of U.S. veterans with opioid use disorderRachel Vickers-Smith, Richard C Crist, Rachel L Kember, et al.
The American Journal on Addictions|September 5, 2008
Study blinding and correlations between perceived group assignment and outcome in a cocaine pharmacotherapy trialCatharine E Fairbairn, William D Dundon, Hu Xie, et al.
Addictive Behaviors|September 29, 2009
Combined effects of alcohol and hepatitis C: a secondary analysis of alcohol use biomarkers and high-risk behaviors from two medication trials for alcohol dependenceJennifer G Plebani, Carlos F Tirado, Helen M Pettinati, et al.
Journal of Substance Abuse Treatment|October 13, 2007
Why do those who request smoking treatment fail to attend the first appointment?Peter Gariti, Sarah Levin, Thomas Whittingham, et al.
Journal of Addiction Medicine|January 5, 2026
Testing the Efficacy of an Adaptive Approach to Delivering Psychosocial Interventions in Office-based Buprenorphine TreatmentKaren L Dugosh, S Brook Burkley, James R McKay, et al.
The American Journal on Addictions|February 10, 2004
Cocaine dependence severity predicts outcome in outpatient detoxification from cocaine and alcoholKyle M Kampman, Helen M Pettinati, Joseph R Volpicelli, et al.
Drug and Alcohol Dependence|September 1, 2015
A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependenceKyle M Kampman, Kevin G Lynch, Helen M Pettinati, et al.
Addictive Behaviors|December 15, 2007
A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependenceHelen M Pettinati, Kyle M Kampman, Kevin G Lynch, et al.
Journal of Addiction Medicine|October 3, 2023
Nonopioid Substance Use among Patients Who Recently Initiated Office-based Buprenorphine TreatmentKaren L Dugosh, Michelle R Lent, S Brook Burkley, et al.
JAMA|October 14, 2010
Buprenorphine implants for treatment of opioid dependence: a randomized controlled trialWalter Ling, Paul Casadonte, George Bigelow, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
The American Journal of Drug and Alcohol Abuse|October 29, 2025
Racial and ethnic disparities in buprenorphine retention and treatment outcome in a longitudinal cohort of U.S. veterans with opioid use disorderRachel Vickers-Smith, Richard C Crist, Rachel L Kember, et al.
The American Journal on Addictions|September 5, 2008
Study blinding and correlations between perceived group assignment and outcome in a cocaine pharmacotherapy trialCatharine E Fairbairn, William D Dundon, Hu Xie, et al.
Addictive Behaviors|September 29, 2009
Combined effects of alcohol and hepatitis C: a secondary analysis of alcohol use biomarkers and high-risk behaviors from two medication trials for alcohol dependenceJennifer G Plebani, Carlos F Tirado, Helen M Pettinati, et al.
Journal of Substance Abuse Treatment|October 13, 2007
Why do those who request smoking treatment fail to attend the first appointment?Peter Gariti, Sarah Levin, Thomas Whittingham, et al.
Journal of Addiction Medicine|January 5, 2026
Testing the Efficacy of an Adaptive Approach to Delivering Psychosocial Interventions in Office-based Buprenorphine TreatmentKaren L Dugosh, S Brook Burkley, James R McKay, et al.
The American Journal on Addictions|February 10, 2004
Cocaine dependence severity predicts outcome in outpatient detoxification from cocaine and alcoholKyle M Kampman, Helen M Pettinati, Joseph R Volpicelli, et al.
Drug and Alcohol Dependence|September 1, 2015
A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependenceKyle M Kampman, Kevin G Lynch, Helen M Pettinati, et al.
Addictive Behaviors|December 15, 2007
A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependenceHelen M Pettinati, Kyle M Kampman, Kevin G Lynch, et al.
Journal of Addiction Medicine|October 3, 2023
Nonopioid Substance Use among Patients Who Recently Initiated Office-based Buprenorphine TreatmentKaren L Dugosh, Michelle R Lent, S Brook Burkley, et al.
JAMA|October 14, 2010
Buprenorphine implants for treatment of opioid dependence: a randomized controlled trialWalter Ling, Paul Casadonte, George Bigelow, et al.
Pageof 9